España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Icecure Medical
ICCM
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$1.25
0.02
1.63%
At close: -
$1.28
0.03
2.40%
After Hours: 7:46 PM EDT
Get Report
Comment
Icecure Medical (ICCM) Forecast
News
Earnings
Icecure Medical (ICCM) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Icecure Medical (NASDAQ:ICCM) Stock
Icecure Medical Stock (NASDAQ: ICCM)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, January 06, 2025
IceCure Medical Regains Nasdaq Compliance
Benzinga Newsdesk
Friday, January 03, 2025
IceCure Received Intention To Grant Notice Fr...
Benzinga Newsdesk
Thursday, December 05, 2024
IceCure's ProSense Cryoablation Demonstrates ...
Benzinga Newsdesk
Wednesday, November 27, 2024
HC Wainwright & Co. Reiterates Buy on Icecure...
Benzinga Newsdesk
Tuesday, November 26, 2024
Icecure Medical Earnings Review: Q3 Summary
Benzinga Insights
IceCure Medical Reports 36% Sales Growth In T...
Benzinga Newsdesk
Earnings Scheduled For November 26, 2024
Benzinga Insights
Monday, November 25, 2024
What to Expect from Icecure Medical's Earnings
Benzinga Insights
IceCure Medical Receives Notice Of Allowance ...
Benzinga Newsdesk
Tuesday, November 19, 2024
IceCure's ProSense Chosen For Breast Cryoabla...
Benzinga Newsdesk
Friday, November 08, 2024
HC Wainwright & Co. Reiterates Buy on Icecure...
Benzinga Newsdesk
Tuesday, October 29, 2024
IceCure Medical shares are trading higher aft...
Benzinga Newsdesk
IceCure Medical Announces That A Large Numbe...
Benzinga Newsdesk
Monday, October 21, 2024
IceCure Medical Secures Notice Of Allowance F...
Benzinga Newsdesk
Monday, October 07, 2024
IceCure's ProSense Cryoablation Featured In S...
Benzinga Newsdesk
Tuesday, September 24, 2024
IceCure's ICE3 5-Year Trial Results Published...
Benzinga Newsdesk
Monday, September 16, 2024
IceCure Medical Announces Study Published In ...
Benzinga Newsdesk
Thursday, September 12, 2024
HC Wainwright & Co. Reiterates Buy on Icecure...
Benzinga Newsdesk
IceCure Announces FDA Advisory Panel Meeting ...
Benzinga Newsdesk
Wednesday, August 28, 2024
USPTO Grants Notice Of Allowance For Addition...
Benzinga Newsdesk
Wednesday, August 21, 2024
HC Wainwright & Co. Maintains Buy on Icecure ...
Benzinga Newsdesk
Tuesday, August 20, 2024
IceCure Medical shares are trading higher aft...
Benzinga Newsdesk
Icecure Medical Q2 2024 GAAP EPS $(0.06) Beat...
Benzinga Newsdesk
IceCure Medical Reports H1 EPS Of $(0.14), U...
Benzinga Newsdesk
Wednesday, August 14, 2024
IceCure Says The Study Concluded That 'Most N...
Benzinga Newsdesk
IceCure Medical Announces Publication Of Inde...
Benzinga Newsdesk
Wednesday, August 07, 2024
IceCure Medical Announces Publication Of Inde...
Benzinga Newsdesk
Monday, July 22, 2024
IceCure Medical Presents Key Findings On ProS...
Benzinga Newsdesk
Friday, July 19, 2024
IceCure Medical Receives Receipt From Nasdaq ...
Benzinga Newsdesk
Tuesday, July 09, 2024
IceCure Medical Announces Independent Study R...
Benzinga Newsdesk
Tuesday, July 02, 2024
HC Wainwright & Co. Reiterates Buy on Icecure...
Benzinga Newsdesk
Monday, July 01, 2024
U.S. FDA Grants Regulatory Clearance To IceCu...
Benzinga Newsdesk
Monday, June 17, 2024
Why Nurix Therapeutics Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Wednesday, June 12, 2024
IceCure Medical Reports Data From Its Kidney ...
Benzinga Newsdesk
Wednesday, June 05, 2024
HC Wainwright & Co. Reiterates Buy on Icecure...
Benzinga Newsdesk
Tuesday, June 04, 2024
IceCure Medical Announces FDA Advisory Panel ...
Benzinga Newsdesk
Wednesday, May 29, 2024
HC Wainwright & Co. Reiterates Buy on Icecure...
Benzinga Newsdesk
Tuesday, May 28, 2024
Icecure Medical Q1 EPS $(0.08), Inline, Sales...
Benzinga Newsdesk
Wednesday, May 15, 2024
The Oncology Institute, Inc. Reports Q1 Loss, Lags Revenue Estimates
Zacks
Tuesday, May 07, 2024
IceCure Is Expected To Receive A Total Of $13...
Benzinga Newsdesk
Independent Study Results In Japan Demonstrat...
Benzinga Newsdesk
Tuesday, April 16, 2024
HC Wainwright & Co. Reiterates Buy on Icecure...
Benzinga Newsdesk
Monday, April 15, 2024
IceCure Medical Reports Final ICE3 Breast Can...
Benzinga Newsdesk
Thursday, April 04, 2024
HC Wainwright & Co. Reiterates Buy on Icecure...
Benzinga Newsdesk
Icecure Medical Q4 EPS $(0.07), Inline, Sales...
Benzinga Newsdesk
Wednesday, April 03, 2024
As Of March 31, 2024, IceCure Medical Had Cas...
Benzinga Newsdesk
Icecure Medical FY EPS $(0.32), Inline, Sales...
Benzinga Newsdesk
Earnings Scheduled For April 3, 2024
Benzinga Insights
Tuesday, April 02, 2024
IceCure Submits 510(k) With FDA For Clearance...
Benzinga Newsdesk
Wednesday, March 20, 2024
Alliance Global Partners Maintains Buy on Ice...
Benzinga Newsdesk
Show More
